한글목차

세계 심장 펌프 기기 시장의 미래는 병원 및 심장 센터 시장에 기회가 있을 것으로 보입니다. 세계 심장 펌프 기기 시장은 2025-2031년 20.3%의 연평균 복합 성장률(CAGR)로 2031년까지 약 80억 달러에 달할 것으로 예측됩니다. 이 시장의 주요 촉진요인은 비만 유병률 증가, 심장 이식 수술에서 이 장치의 사용 증가, 심혈관 질환의 발생률 증가입니다.

• Lucintel의 예측에 따르면, 유형별로는 심장이식 적응증이 없는 심부전 환자들 사이에서 수요가 증가함에 따라 이식형이 예측 기간 동안 더 큰 부문을 차지할 것으로 예상했습니다.
• 최종 용도 카테고리에서 병원은 수술 건수, 심혈관 질환 증가, 유능한 전문의의 존재로 인해 병원에서 심장 펌프 기기 수요가 증가함에 따라 병원이 계속해서 큰 부문을 차지할 것으로 예측됩니다.
• 지역별로는 북미가 높은 인구의 심장병 유병률, 탄탄한 의료 인프라, 주요 기업의 존재로 인해 예측 기간 동안 가장 규모가 큰 지역으로 남을 것으로 예측됩니다.

심장 펌프 기기 시장의 전략적 성장 기회

심장 펌프 기기 시장과 관련된 다양한 응용 분야에는 수많은 전략적 성장 기회가 존재합니다. 이러한 기회를 이해하는 것은 심혈관 치료 및 기술 변화에 적극적으로 참여하고자 하는 이해관계자들에게 중요합니다.

• 신흥 시장 진출: 신흥 시장 진출은 심장질환 발병률 증가에 따른 의료 투자 증가로 인해 성장 전망이 밝습니다. 수요가 존재하는 지역을 대상으로 비용 효율적이고 이용하기 쉬운 제품을 개발함으로써 시장 개척이 가능할 것으로 예측됩니다.
• 디지털 헬스 기술 통합: 심실보조장치(VAD)에 디지털 헬스 기술을 통합하여 환자 모니터링 및 관리를 개선할 수 있습니다. 원격 모니터링은 기기의 기능뿐만 아니라 실시간 데이터 분석을 통해 임상 결과를 개선하고 새로운 시장을 창출할 수 있습니다.
• 환자 중심 설계 개발: 환자 중심 설계에 초점을 맞추면 심혈관 펌프의 보급을 촉진할 수 있습니다. 환자의 편안함, 사용 편의성, 생활 방식과의 원활한 통합을 촉진하는 혁신은 수요의 주요 원동력이 될 수 있으며, 환자의 치료 순응도를 높일 수 있습니다.
• 생체 적합성 개발: 생체 적합성 심장 펌프의 개발은 새로운 성장 기회를 창출합니다. 이 기술은 합병증 발생 가능성을 낮추고, 기기의 수명을 연장하여 환자와 의료진 모두에게 매력적인 기기가 되어 시장을 확대할 수 있습니다.
• 파트너십 및 협업: 제조업체, 연구기관, 의료 서비스 제공업체 간의 전략적 파트너십은 혁신과 시장 진입을 가속화하고 있습니다. 이러한 협력 관계는 기술 발전뿐만 아니라 시장 확대로 이어집니다.

이러한 기회는 심장 펌프 기기 시장에서 성장의 유망한 미래를 보여줍니다. 이해관계자들은 새로운 트렌드와 전략적 이니셔티브를 활용하여 혁신을 창출하고 환자의 건강 상태를 개선함으로써 새로운 시장을 창출할 수 있습니다.

심장 펌프 기기 시장 성장 촉진요인 및 과제

심장 펌프 기기 시장의 개척과 성장에는 다양한 촉진요인과 과제가 영향을 미칩니다. 이러한 요인을 이해하는 것은 심장 치료 제공의 중요한 문제를 해결하면서 이 시장을 가로지르는 데 필수적입니다.

심장 펌프 기기 시장을 이끄는 요인은 다음과 같습니다.

1. 기술 발전: 시장 확대의 요인은 생체적합성이 뛰어난 차세대 LVAD(좌심보조순환장치) 등의 기술 발전입니다. 이러한 개선을 통해 이들 장치는 더 우수한 성능을 발휘하게 되었고, 사용자별 채택률이 높아지면서 높은 수요로 이어지고 있습니다.

2. 심혈관 질환의 유병률 증가: 심혈관 질환의 유병률은 전 세계적으로 증가하고 있으며, 그 결과 심장 펌프 시장 점유율은 전 세계적으로 확대되고 있습니다. 더 나은 치료를 원하는 환자가 증가함에 따라 첨단 심장 펌프 기술이 요구되고 있습니다.

3. 제약 승인 및 지원: 새로운 심장 펌프 기술에 대한 지원과 함께 규제 당국의 승인은 시장 개척을 가속화하고 있습니다. 간소화된 승인 절차와 함께 혁신적인 가젯이 병원 및 클리닉에 더 빨리 도입되어 치료 옵션을 넓히고 있습니다.

4. 연구개발 투자: 연구개발비용 증가는 혁신적인 심장 펌프 기술의 성장에 기여하고 있습니다. 이러한 자금 조달은 보다 효율적이고 효과적인 기기 개발을 촉진하고 시장 개척을 촉진하고 있습니다.

5. 인식 개선 및 교육: 환자 및 의료진의 심장 질환 및 첨단 접근법에 대한 지식이 향상됨에 따라 심혈관 펌프에 대한 수요가 증가하고 있습니다. 환자와 의료진의 이해도가 높아짐에 따라 이러한 기술의 채택이 증가하고 있습니다.

심장 펌프 기기 시장의 과제는 다음과 같습니다.

1. 첨단 장비의 높은 비용: 첨단 심장 펌프 기기와 관련된 높은 비용은 시장 성장의 과제가 되고 있습니다. 고가의 기술은 특히 의료 예산이 적은 지역에서는 접근성과 채택을 제한할 수 있습니다.

2. 규제 및 상환 장애물: 이 산업이 직면한 규제 및 상환 장애물을 극복하기 위해 제조업체는 종종 어려움을 겪습니다. 복잡한 승인 과정과 상환 문제는 시장 진입 과정을 지연시키고 장비의 수용률에 부정적인 영향을 미칠 수 있습니다.

3. 기기 합병증 및 관리 : 감염 및 기기 오작동과 같은 문제는 심장 펌프와 관련된 의료 합병증을 유발하고 환자 치료 및 안전 문제를 압박합니다. 이러한 문제를 해결하는 것은 기기의 신뢰성과 함께 임상 결과를 개선하기 위해 점점 더 중요해지고 있습니다.

심장 펌프 기기 시장의 개척과 성장에는 몇 가지 촉진요인과 과제가 영향을 미치고 있습니다. 이해관계자들이 이러한 요인들을 해결함으로써 심혈관 치료의 개선에 기여하면서 시장을 성공적으로 극복할 수 있습니다.

목차

제1장 주요 요약

제2장 세계의 심장 펌프 기기 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 산업 촉진요인과 과제

제3장 시장 동향과 예측 분석(2019-2031년)

• 거시경제 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 심장 펌프 기기 시장 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 심장 펌프 기기 시장(유형별)
  • 이식형 심장 펌프 기기
  • 체외 심장 펌프 기기
• 세계의 심장 펌프 기기 시장(제품 유형별)
  • 심실 보조 장치(VAD)
  • 전인공 심장(TAH)
  • 대동맥내 풍선 펌프(IABP)
  • 체외막형 인공폐(ECMO)
• 세계의 심장 펌프 기기 시장(최종 용도별)
  • 병원
  • 심장센터
  • 기타

제4장 지역별 시장 동향과 예측 분석(2019-2031년)

• 지역별 심장 펌프 기기 시장
• 북미의 심장 펌프 기기 시장
• 유럽의 심장 펌프 기기 시장
• 아시아태평양의 심장 펌프 기기 시장
• 기타 지역의 심장 펌프 기기 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter의 Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 유형별 : 세계의 심장 펌프 기기 시장 성장 기회
  • 제품 유형별 : 세계의 심장 펌프 기기 시장 성장 기회
  • 최종 용도별 : 세계의 심장 펌프 기기 시장 성장 기회
  • 지역별 심장 펌프 기기 시장 성장 기회
• 세계 심장 펌프 기기 시장의 새로운 동향
• 전략 분석
  • 신제품 개발
  • 세계의 심장 펌프 기기 시장 생산능력 확대
  • 세계 심장 펌프 기기 시장에서의 인수합병(M&A) 및 합작투자(JV)
  • 인증 및 라이선싱

제7장 주요 기업 개요

• Abbott
• ABIOMED
• CorWave
• LivaNova
• Berlin Heart
• SynCardia Systems
• Jarvik Heart
• BiVACOR
• Leviticus Cardio
• Evaheart

영문목차

The future of the global heart pump device market looks promising with opportunities in the hospital and cardiac center markets. The global heart pump device market is expected to reach an estimated $8 billion by 2031 with a CAGR of 20.3% from 2025 to 2031. The major drivers for this market are the growing prevalence of obesity, the rising use of this device in heart transplant procedures, and the escalating incidence of cardiovascular disorders.

• Lucintel forecasts that, Within the type category, implanted will remain the larger segment over the forecast period due to its rising need among patients suffering from heart failure who are not eligible for a heart transplant.
• Within the end-use category, hospitals will remain the larger segment due to the increased need for heart pump devices in this setting owing to the number of surgeries being done, growing incidences of cardiovascular disorders, and availability of qualified specialists.
• In terms of regions, North America will remain the largest region over the forecast period due to high heart disease rates among the population, the existence of robust healthcare infrastructure, and the presence of key players in the region.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Heart Pump Device Market

The heart pump device market is evolving with emerging trends that mirror advancements in technology, patient care, and changes within the market itself. Understanding these trends can therefore provide insight into how this industry has changed over time and where it may be headed next in terms of innovative heart pumps.

• Miniaturization of Devices: There is a trend toward miniaturization and efficiency improvement with smaller devices. This can be attributed to advances in materials science and engineering that make procedures less invasive, thus enhancing patients' comfort. Small implants also allow better integration into patients' lives and enable them to move around freely without any hassle.
• Integration with Digital Health: This trend has seen heart pumps integrated into digital health technologies. Remote monitoring along with data analytics has greatly improved device management and patient care. This opens up real-time assessment of both device performance and patient health, thereby leading to prompt actions or targeted curative procedures through such insights.
• Improved Biocompatibility: Advances in material science have led to improved biocompatibility of ventricular assist devices. New materials and coatings have reduced the risks of complications and resulted in better long-term performance of devices. Ensuring biocompatibility is crucial for patient safety and device longevity.
• Focus on Patient-Centric Designs: There has been an increasing focus on designing heart pumps with patients' comfort and lifestyle in mind. These include ergonomic designs, reduced device profiles, and user-friendly interfaces. This trend aims to improve how patients experience healthcare services and their compliance with therapies.
• Expansion into Emerging Markets: The heart pump market is entering emerging markets due to increased healthcare investments and the growing incidence of cardiovascular diseases. In these regions, firms are developing cost-effective solutions that enhance accessibility and affordability concerning heart pump technologies.

These emerging trends are redefining the heart pump device market by improving device functionality, enhancing patient outcomes, and expanding market reach. The shift toward miniaturization, digital integration, or patient-centric design characterizes a broader transformation toward more effective and accessible cardiovascular care.

Recent Developments in the Heart Pump Device Market

In recent times there have been significant advancements within the heart pump device market due to technological advancements made as well as regulatory approvals granted thereby expanding the industry's geographical footprint. Such developments are defining future treatment approaches for cardiovascular complications globally thus leading to improved patient results.

• Next-Generation LVADs: Significant progress has been achieved by introducing next-generation Left Ventricular Assist Devices (LVADs) which are more durable than ever before leading to fewer complications. Through this, these devices offer better clinical outcomes for patients while extending their lifespan addressing key problems concerning HF therapy at hand.
• FDA Approvals for Innovative Designs: Recently FDA-approved new designs for artificial hearts have widened treatment options for many patients who need them across America. Among other things, some innovations include wireless monitoring systems such as those with advanced features like the one that can detect some chemicals contributing to better patient management and care. Emergence of Local Manufacturers:
• In developing markets, local manufacturing has resulted in cheap heart pumps. Such a trend makes advanced cardiovascular technologies more accessible and affordable, particularly for high HF disease burden regions.
• Technological Advances in Biocompatibility: With advancements in materials & coatings, the biocompatibility of artificial hearts is enhanced. New methods are reducing risks of complications and ensuring longer functioning as they are crucial for long-term patient care.
• Increased Investment in R&D: Increased R&D investment stimulates innovation in heart pump technology. Firms are striving to develop more efficient, durable, and patient-friendly units thereby pushing the limits of current artificial heart capabilities.

Through technology enhancement, expanded access or improved patient outcomes, these developments have significantly impacted on heart pump device market. The ongoing advances indicate a commitment towards addressing HF challenge as well as advancing cardiovascular care globally for every individual suffering from it.

Strategic Growth Opportunities for Heart Pump Device Market

The numerous strategic growth opportunities exist within various applications related to heart pump device market. Understanding these opportunities becomes important for stakeholders who want to participate actively in changing landscape of cardiovascular treatment and technology.

• Expansion into Emerging Markets: Going to emerging markets provides excellent growth prospects due to increased investments in healthcare along with higher incidence of cardiac diseases. This can lead to new markets expansion by developing cost effective and accessible products for those areas where demand exists.
• Integration of Digital Health Technologies: There is an opportunity to integrate digital health technologies with ventricular assist devices that could improve patients' monitoring and management. Remote monitoring enables device function as well as better clinical results through real-time data analytics hence creating new marketplaces.
• Patient-Centric Designs Development: A focus on patient-centric designs can encourage the uptake of cardiovascular pumps. Innovations that promote patients' comfort, ease of use, and seamless integration with their way of life can be major drivers of demand and enhance patient adherence to treatment.
• Biocompatibility Developments: Developing heart pumps that have better biocompatibility creates new opportunities for growth. This technology lowers the chance of complications occurring and increases the lifespan of the devices, making them more attractive to patients and providers alike hence creating wider markets.
• Partnerships and Collaborations: Strategic partnerships between manufacturers, research institutions, and healthcare providers can accelerate innovation as well as market entry. These collaborations result in advancement in technologies as well as expansive market coverage.

These opportunities reveal a promising future for growth within the heart pump device market. Stakeholders may utilize emerging trends along with strategic initiatives to create innovations and improve health outcomes for their patients thereby creating new markets.

Heart Pump Device Market Driver and Challenges

Different drivers and challenges influence the development and growth of the heart pump device market. Comprehending these elements is vital to traversing this marketplace while addressing critical problems in cardiac care delivery.

The factors responsible for driving the heart pump device market include:

1. Technological Advancements: Market expansion is caused by technological advancements such as next generation LVADs (Left Ventricular Assist Devices) which have better biocompatibility. Such improvements make these devices perform better thus contributing to increased adoption rates by users leading to high demands.

2. Rising Prevalence of Cardiovascular Diseases: The prevalence of cardiovascular diseases worldwide has grown resulting in increased heart pump market share globally. Increased numbers of patients are seeking better treatments for their lives thus needing advanced heart pumping technologies.

3. Regulatory Approvals and Support: Regulatory approvals together with support for novel heart pump technologies are driving overall market development at an increasing pace. Favorable legislation coupled with streamlined approval processes help quicken introduction of innovative gadgets into clinics or hospitals expanding treatment options.

4. Investment in Research and Development: Rising expenditure on R&D is contributing towards the growth of innovative heart pump technologies. This funding type facilitates the creation of devices that are more efficient and effective thus boosting market development.

5. Growing Awareness and Education: Improved patient as well as health professional knowledge about heart disease and advanced approach has led to increased demand for cardiovascular pumps. Greater understanding among patients and healthcare providers supports the adoption of such technologies.

Challenges in the heart pump device market are:

1. High Costs of Advanced Devices: The high costs associated with advanced heart pump devices pose a challenge for market growth. Expensive technologies can limit accessibility and adoption, particularly in regions with lower healthcare budgets.

2. Regulatory and Reimbursement Hurdles: Manufacturers often struggle to navigate their way through regulatory as well as reimbursement hurdles facing this industry. Complex approval processes coupled with reimbursement issues may slow down the process of entering the market thereby negatively influencing device acceptance rates.

3. Device Complications and Management: Problems like infections or device malfunctioning among others result in medical complications associated with cardiac pumps which then put pressure on patient care and safety issues. Fixing these problems will become increasingly important for enhancing clinical outcomes along with device reliability.

Several drivers or challenges impact the heart pump device market leading to its development or growth. These factors should be addressed by stakeholders so that they successfully navigate across the market while contributing towards improved cardiovascular care.

List of Heart Pump Device Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies heart pump device companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the heart pump device companies profiled in this report include-

• Abbott
• ABIOMED
• CorWave
• LivaNova
• Berlin Heart
• SynCardia Systems
• Jarvik Heart
• BiVACOR
• Leviticus Cardio
• Evaheart

Heart Pump Device by Segment

The study includes a forecast for the global heart pump device market by type, product type, end use, and region.

Heart Pump Device Market by Type [Analysis by Value from 2019 to 2031]:

• Implanted Heart Pump Devices
• Extracorporeal Heart Pump Devices

Heart Pump Device Market by Product Type [Analysis by Value from 2019 to 2031]:

• Ventricular Assist Devices (VADs)
• Total Artificial Hearts (TAHs)
• Intra-Aortic Balloon Pumps (IABPs)
• Extracorporeal Membrane Oxygenation (ECMO)

Heart Pump Device Market by End Use [Analysis by Value from 2019 to 2031]:

• Hospitals
• Cardiac Centers
• Others

Heart Pump Device Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Heart Pump Device Market

The market for heart pump devices is moving rapidly due to technological breakthroughs and the rise in demand for effective cardiovascular treatment. Significant strides have been made toward innovation and market growth in the U.S., China, Germany, India, and Japan. These improvements are part of a continued effort to combat heart failure and enhance patient outcomes with advanced cardiac devices.

• United States: Recent developments in the U.S. heart pump device market include the FDA's approval of a new generation of Left Ventricular Assist Devices (LVADs) that are more durable and have fewer complications. Innovations from companies like Abbott and Medtronic are leading the way with better integration and remote monitoring capabilities. These improvements aim to enhance patients' quality of life and broaden the use of heart pumps in treating advanced stages of heart failure.
• China: In China, investment in cardiovascular healthcare, coupled with technological advances, has contributed to growth within the heart pump device market. Chinese firms like MicroPort and LifeTech are developing affordable heart pumps tailored to their local markets. Such innovations make it easier for people to access affordable heart pumps, thus helping to control escalating disease burdens.
• Germany: On a European scale, Germany plays a leading role in heart pump technology advancement, with recent innovations focusing on miniature versions that can be implanted beneath a patient's skin. Companies like Berlin Heart and Fresenius are developing new models that guarantee improved patient comfort and longer durability. This development stems from Germany's strong healthcare infrastructure and increased R&D efforts, establishing it as an innovation leader for heart pumps.
• India: The heart pump device market in India is evolving based on affordability and accessibility concerns. Domestic manufacturers are creating cost-effective alternatives for coronary artery disease, which is prevalent among a larger population segment characterized by inadequate access to these devices given its purchasing power parity compared to other countries. The government's approach, along with relationships formed with foreign organizations, has aided in the introduction of modern technologies aimed at advancing care and improving treatment outcomes for patients with cardiac failure.
• Japan: Japan is making strides in heart pump technology with a focus on next-generation devices that offer enhanced biocompatibility and functionality. Compactness, durability, and heart pumps for the elderly population are among the critical concerns pursued by companies like Terumo and Japan Lifeline. These initiatives are improving patient outcomes while widening the application of cardiac support devices for heart failure management.

Features of the Global Heart Pump Device Market

Market Size Estimates: Heart pump device market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Heart pump device market size by type, product type, end use, and region in terms of value ($B).

Regional Analysis: Heart pump device market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, product types, end uses, and regions for the heart pump device market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the heart pump device market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the heart pump device market by type (implanted heart pump devices and extracorporeal heart pump devices), product type (ventricular assist devices (VADs), total artificial hearts (TAHs), intra-aortic balloon pumps (IABPs), and extracorporeal membrane oxygenation (ECMO)), end use (hospitals, cardiac centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Heart Pump Device Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Heart Pump Device Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Heart Pump Device Market by Type
  • 3.3.1: Implanted Heart Pump Devices
  • 3.3.2: Extracorporeal Heart Pump Devices
• 3.4: Global Heart Pump Device Market by Product Type
  • 3.4.1: Ventricular Assist Devices (VADs)
  • 3.4.2: Total Artificial Hearts (TAHs)
  • 3.4.3: Intra-Aortic Balloon Pumps (IABPs)
  • 3.4.4: Extracorporeal Membrane Oxygenation (ECMO)
• 3.5: Global Heart Pump Device Market by End Use
  • 3.5.1: Hospitals
  • 3.5.2: Cardiac Centers
  • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Heart Pump Device Market by Region
• 4.2: North American Heart Pump Device Market
  • 4.2.1: North American Market by Type: Implanted Heart Pump Devices and Extracorporeal Heart Pump Devices
  • 4.2.2: North American Market by End Use: Hospitals, Cardiac Centers, and Others
• 4.3: European Heart Pump Device Market
  • 4.3.1: European Market by Type: Implanted Heart Pump Devices and Extracorporeal Heart Pump Devices
  • 4.3.2: European Market by End Use: Hospitals, Cardiac Centers, and Others
• 4.4: APAC Heart Pump Device Market
  • 4.4.1: APAC Market by Type: Implanted Heart Pump Devices and Extracorporeal Heart Pump Devices
  • 4.4.2: APAC Market by End Use: Hospitals, Cardiac Centers, and Others
• 4.5: ROW Heart Pump Device Market
  • 4.5.1: ROW Market by Type: Implanted Heart Pump Devices and Extracorporeal Heart Pump Devices
  • 4.5.2: ROW Market by End Use: Hospitals, Cardiac Centers, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Heart Pump Device Market by Type
  • 6.1.2: Growth Opportunities for the Global Heart Pump Device Market by Product Type
  • 6.1.3: Growth Opportunities for the Global Heart Pump Device Market by End Use
  • 6.1.4: Growth Opportunities for the Global Heart Pump Device Market by Region
• 6.2: Emerging Trends in the Global Heart Pump Device Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Heart Pump Device Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Heart Pump Device Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Abbott
• 7.2: ABIOMED
• 7.3: CorWave
• 7.4: LivaNova
• 7.5: Berlin Heart
• 7.6: SynCardia Systems
• 7.7: Jarvik Heart
• 7.8: BiVACOR
• 7.9: Leviticus Cardio
• 7.10: Evaheart